nodes	percent_of_prediction	percent_of_DWPC	metapath
Penicillamine—Polymyositis—Cimetidine—obesity	0.154	0.192	CcSEcCtD
Penicillamine—SLCO1B1—Irinotecan Pathway—NPC1—obesity	0.0273	0.154	CbGpPWpGaD
Penicillamine—Monocytosis—Sibutramine—obesity	0.024	0.0299	CcSEcCtD
Penicillamine—Alkaline phosphatase serum increased—Topiramate—obesity	0.0208	0.026	CcSEcCtD
Penicillamine—Hyperplasia—Topiramate—obesity	0.019	0.0236	CcSEcCtD
Penicillamine—SLCO1B1—Irinotecan Pathway—CES1—obesity	0.0189	0.107	CbGpPWpGaD
Penicillamine—Pemphigoid—Topiramate—obesity	0.0174	0.0217	CcSEcCtD
Penicillamine—L-Alanine—GPT—obesity	0.0153	0.746	CrCbGaD
Penicillamine—Bone marrow depression—Diethylpropion—obesity	0.0115	0.0143	CcSEcCtD
Penicillamine—Pemphigus—Topiramate—obesity	0.0114	0.0142	CcSEcCtD
Penicillamine—Bone marrow depression—Cimetidine—obesity	0.0109	0.0136	CcSEcCtD
Penicillamine—Pruritus generalised—Bupropion—obesity	0.0103	0.0128	CcSEcCtD
Penicillamine—SLCO1B1—Drug Induction of Bile Acid Pathway—NR1I3—obesity	0.00866	0.0487	CbGpPWpGaD
Penicillamine—Appetite absent—Orlistat—obesity	0.00817	0.0102	CcSEcCtD
Penicillamine—SLCO1B1—Drug Induction of Bile Acid Pathway—NR1I2—obesity	0.00792	0.0445	CbGpPWpGaD
Penicillamine—Abdominal pain upper—Phendimetrazine—obesity	0.00721	0.009	CcSEcCtD
Penicillamine—Aplastic anaemia—Cimetidine—obesity	0.00691	0.00862	CcSEcCtD
Penicillamine—Appetite absent—Bupropion—obesity	0.00689	0.0086	CcSEcCtD
Penicillamine—SLCO1B1—Drug Induction of Bile Acid Pathway—SULT2A1—obesity	0.00656	0.0369	CbGpPWpGaD
Penicillamine—Pruritus generalised—Topiramate—obesity	0.00655	0.00816	CcSEcCtD
Penicillamine—Eruption—Sibutramine—obesity	0.0064	0.00798	CcSEcCtD
Penicillamine—Thrombocytosis—Sibutramine—obesity	0.00633	0.00789	CcSEcCtD
Penicillamine—Breast enlargement—Sibutramine—obesity	0.00607	0.00757	CcSEcCtD
Penicillamine—Hepatic failure—Cimetidine—obesity	0.00595	0.00742	CcSEcCtD
Penicillamine—SLCO1B1—Irinotecan Pathway—BCHE—obesity	0.00581	0.0327	CbGpPWpGaD
Penicillamine—Dermatitis exfoliative—Cimetidine—obesity	0.00566	0.00706	CcSEcCtD
Penicillamine—Breast enlargement—Bupropion—obesity	0.00529	0.0066	CcSEcCtD
Penicillamine—L-Cysteine—GOT1—obesity	0.00519	0.254	CrCbGaD
Penicillamine—Agitation—Methamphetamine—obesity	0.00497	0.0062	CcSEcCtD
Penicillamine—SLCO1B1—Transport of vitamins, nucleosides, and related molecules—SLC27A1—obesity	0.00489	0.0275	CbGpPWpGaD
Penicillamine—Toxic epidermal necrolysis—Cimetidine—obesity	0.00481	0.006	CcSEcCtD
Penicillamine—Agitation—Benzphetamine—obesity	0.0048	0.00598	CcSEcCtD
Penicillamine—Pancytopenia—Diethylpropion—obesity	0.00461	0.00575	CcSEcCtD
Penicillamine—SLCO1B1—Recycling of bile acids and salts—NCOA1—obesity	0.00455	0.0256	CbGpPWpGaD
Penicillamine—Pancreatitis—Cimetidine—obesity	0.00453	0.00565	CcSEcCtD
Penicillamine—Rash erythematous—Bupropion—obesity	0.00448	0.00559	CcSEcCtD
Penicillamine—Pancytopenia—Cimetidine—obesity	0.00439	0.00547	CcSEcCtD
Penicillamine—Agitation—Phendimetrazine—obesity	0.00437	0.00545	CcSEcCtD
Penicillamine—Glossitis—Sibutramine—obesity	0.00427	0.00532	CcSEcCtD
Penicillamine—Leukocytosis—Sibutramine—obesity	0.00419	0.00522	CcSEcCtD
Penicillamine—Anorexia—Benzphetamine—obesity	0.00406	0.00506	CcSEcCtD
Penicillamine—Renal failure—Cimetidine—obesity	0.00405	0.00505	CcSEcCtD
Penicillamine—Agranulocytosis—Diethylpropion—obesity	0.00404	0.00504	CcSEcCtD
Penicillamine—Agranulocytosis—Cimetidine—obesity	0.00384	0.00479	CcSEcCtD
Penicillamine—Agitation—Phenylpropanolamine—obesity	0.00373	0.00466	CcSEcCtD
Penicillamine—Glossitis—Bupropion—obesity	0.00372	0.00464	CcSEcCtD
Penicillamine—Decreased appetite—Benzphetamine—obesity	0.0037	0.00462	CcSEcCtD
Penicillamine—Anorexia—Phendimetrazine—obesity	0.0037	0.00462	CcSEcCtD
Penicillamine—Leukocytosis—Bupropion—obesity	0.00365	0.00455	CcSEcCtD
Penicillamine—Agitation—Phentermine—obesity	0.00357	0.00446	CcSEcCtD
Penicillamine—Mouth ulceration—Sibutramine—obesity	0.00356	0.00444	CcSEcCtD
Penicillamine—Thrombocytosis—Topiramate—obesity	0.00351	0.00438	CcSEcCtD
Penicillamine—Urticaria—Methamphetamine—obesity	0.00351	0.00438	CcSEcCtD
Penicillamine—Anxiety—Phenylpropanolamine—obesity	0.00345	0.0043	CcSEcCtD
Penicillamine—Alopecia—Diethylpropion—obesity	0.00343	0.00428	CcSEcCtD
Penicillamine—Urticaria—Benzphetamine—obesity	0.00338	0.00422	CcSEcCtD
Penicillamine—Decreased appetite—Phendimetrazine—obesity	0.00337	0.00421	CcSEcCtD
Penicillamine—Lymphadenopathy—Sibutramine—obesity	0.00335	0.00417	CcSEcCtD
Penicillamine—SLCO1B1—Transport of organic anions—ALB—obesity	0.00332	0.0187	CbGpPWpGaD
Penicillamine—Hepatic failure—Orlistat—obesity	0.00328	0.0041	CcSEcCtD
Penicillamine—Blood alkaline phosphatase increased—Sibutramine—obesity	0.00328	0.00409	CcSEcCtD
Penicillamine—Hepatic function abnormal—Sibutramine—obesity	0.00327	0.00408	CcSEcCtD
Penicillamine—Alopecia—Cimetidine—obesity	0.00327	0.00408	CcSEcCtD
Penicillamine—Hypersensitivity—Methamphetamine—obesity	0.00325	0.00406	CcSEcCtD
Penicillamine—Bone marrow depression—Topiramate—obesity	0.00324	0.00404	CcSEcCtD
Penicillamine—Neuropathy—Bupropion—obesity	0.00322	0.00402	CcSEcCtD
Penicillamine—Hypersensitivity—Benzphetamine—obesity	0.00314	0.00391	CcSEcCtD
Penicillamine—Agitation—Diethylpropion—obesity	0.00311	0.00388	CcSEcCtD
Penicillamine—Injury—Sibutramine—obesity	0.00311	0.00387	CcSEcCtD
Penicillamine—Mouth ulceration—Bupropion—obesity	0.0031	0.00387	CcSEcCtD
Penicillamine—Leukopenia—Diethylpropion—obesity	0.00303	0.00378	CcSEcCtD
Penicillamine—Hypoglycaemia—Orlistat—obesity	0.00302	0.00377	CcSEcCtD
Penicillamine—Diarrhoea—Methamphetamine—obesity	0.00302	0.00377	CcSEcCtD
Penicillamine—SLCO1B1—Bile acid and bile salt metabolism—AKR1C3—obesity	0.00301	0.0169	CbGpPWpGaD
Penicillamine—Agitation—Cimetidine—obesity	0.00296	0.00369	CcSEcCtD
Penicillamine—Hypoglycaemia—Sibutramine—obesity	0.00293	0.00365	CcSEcCtD
Penicillamine—Lymphadenopathy—Bupropion—obesity	0.00292	0.00364	CcSEcCtD
Penicillamine—Diarrhoea—Benzphetamine—obesity	0.00291	0.00363	CcSEcCtD
Penicillamine—Leukopenia—Cimetidine—obesity	0.00288	0.00359	CcSEcCtD
Penicillamine—Anxiety—Diethylpropion—obesity	0.00287	0.00358	CcSEcCtD
Penicillamine—Rash erythematous—Topiramate—obesity	0.00285	0.00356	CcSEcCtD
Penicillamine—Hepatic function abnormal—Bupropion—obesity	0.00285	0.00355	CcSEcCtD
Penicillamine—Coagulopathy—Topiramate—obesity	0.00281	0.0035	CcSEcCtD
Penicillamine—Arthralgia—Cimetidine—obesity	0.00274	0.00342	CcSEcCtD
Penicillamine—Anxiety—Cimetidine—obesity	0.00273	0.00341	CcSEcCtD
Penicillamine—Injury—Bupropion—obesity	0.00271	0.00338	CcSEcCtD
Penicillamine—Ageusia—Topiramate—obesity	0.0027	0.00336	CcSEcCtD
Penicillamine—Abdominal pain upper—Orlistat—obesity	0.0027	0.00336	CcSEcCtD
Penicillamine—Diarrhoea—Phendimetrazine—obesity	0.00266	0.00331	CcSEcCtD
Penicillamine—Dermatitis exfoliative—Bupropion—obesity	0.00264	0.00329	CcSEcCtD
Penicillamine—Thrombocytopenia—Cimetidine—obesity	0.00257	0.00321	CcSEcCtD
Penicillamine—Hypoglycaemia—Bupropion—obesity	0.00255	0.00318	CcSEcCtD
Penicillamine—Asthma—Orlistat—obesity	0.00255	0.00318	CcSEcCtD
Penicillamine—Nausea—Benzphetamine—obesity	0.00253	0.00316	CcSEcCtD
Penicillamine—Urticaria—Phentermine—obesity	0.00252	0.00314	CcSEcCtD
Penicillamine—Muscular weakness—Sibutramine—obesity	0.00252	0.00314	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Diethylpropion—obesity	0.00252	0.00314	CcSEcCtD
Penicillamine—Pancreatitis—Orlistat—obesity	0.0025	0.00312	CcSEcCtD
Penicillamine—Asthma—Sibutramine—obesity	0.00247	0.00308	CcSEcCtD
Penicillamine—SLCO1B1—Recycling of bile acids and salts—ALB—obesity	0.00246	0.0138	CbGpPWpGaD
Penicillamine—Eosinophilia—Sibutramine—obesity	0.00244	0.00305	CcSEcCtD
Penicillamine—Hypersensitivity—Phenylpropanolamine—obesity	0.00244	0.00305	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Cimetidine—obesity	0.00239	0.00299	CcSEcCtD
Penicillamine—SLCO1B1—Bile acid and bile salt metabolism—NCOA1—obesity	0.00238	0.0134	CbGpPWpGaD
Penicillamine—Glossitis—Topiramate—obesity	0.00237	0.00296	CcSEcCtD
Penicillamine—Nausea—Phendimetrazine—obesity	0.00231	0.00288	CcSEcCtD
Penicillamine—Abdominal pain upper—Bupropion—obesity	0.00227	0.00284	CcSEcCtD
Penicillamine—Renal failure—Orlistat—obesity	0.00224	0.00279	CcSEcCtD
Penicillamine—Neuropathy peripheral—Orlistat—obesity	0.00223	0.00278	CcSEcCtD
Penicillamine—Muscular weakness—Bupropion—obesity	0.0022	0.00274	CcSEcCtD
Penicillamine—Urticaria—Diethylpropion—obesity	0.00219	0.00274	CcSEcCtD
Penicillamine—Diarrhoea—Phentermine—obesity	0.00217	0.00271	CcSEcCtD
Penicillamine—Renal failure—Sibutramine—obesity	0.00216	0.0027	CcSEcCtD
Penicillamine—Neuropathy peripheral—Sibutramine—obesity	0.00216	0.00269	CcSEcCtD
Penicillamine—Asthma—Bupropion—obesity	0.00215	0.00268	CcSEcCtD
Penicillamine—Hepatobiliary disease—Orlistat—obesity	0.00215	0.00268	CcSEcCtD
Penicillamine—Stomatitis—Sibutramine—obesity	0.00215	0.00268	CcSEcCtD
Penicillamine—Pancreatitis—Bupropion—obesity	0.00211	0.00263	CcSEcCtD
Penicillamine—Vomiting—Phenylpropanolamine—obesity	0.00211	0.00263	CcSEcCtD
Penicillamine—Haematuria—Sibutramine—obesity	0.0021	0.00262	CcSEcCtD
Penicillamine—Rash—Phenylpropanolamine—obesity	0.00209	0.00261	CcSEcCtD
Penicillamine—Dermatitis—Phenylpropanolamine—obesity	0.00209	0.00261	CcSEcCtD
Penicillamine—Body temperature increased—Cimetidine—obesity	0.00208	0.00259	CcSEcCtD
Penicillamine—Haemoglobin—Orlistat—obesity	0.00205	0.00256	CcSEcCtD
Penicillamine—Neuropathy—Topiramate—obesity	0.00205	0.00256	CcSEcCtD
Penicillamine—Pancytopenia—Bupropion—obesity	0.00204	0.00255	CcSEcCtD
Penicillamine—Haemorrhage—Orlistat—obesity	0.00204	0.00255	CcSEcCtD
Penicillamine—Vomiting—Phentermine—obesity	0.00202	0.00252	CcSEcCtD
Penicillamine—Urinary tract disorder—Orlistat—obesity	0.00202	0.00251	CcSEcCtD
Penicillamine—Urethral disorder—Orlistat—obesity	0.002	0.0025	CcSEcCtD
Penicillamine—Rash—Phentermine—obesity	0.002	0.0025	CcSEcCtD
Penicillamine—Dermatitis—Phentermine—obesity	0.002	0.00249	CcSEcCtD
Penicillamine—Haemoglobin—Sibutramine—obesity	0.00199	0.00248	CcSEcCtD
Penicillamine—Haemorrhage—Sibutramine—obesity	0.00198	0.00246	CcSEcCtD
Penicillamine—Mouth ulceration—Topiramate—obesity	0.00198	0.00246	CcSEcCtD
Penicillamine—Nausea—Phenylpropanolamine—obesity	0.00197	0.00246	CcSEcCtD
Penicillamine—Hypersensitivity—Cimetidine—obesity	0.00194	0.00241	CcSEcCtD
Penicillamine—Diarrhoea—Diethylpropion—obesity	0.00189	0.00236	CcSEcCtD
Penicillamine—Nausea—Phentermine—obesity	0.00189	0.00235	CcSEcCtD
Penicillamine—Neuropathy peripheral—Bupropion—obesity	0.00188	0.00235	CcSEcCtD
Penicillamine—Stomatitis—Bupropion—obesity	0.00187	0.00233	CcSEcCtD
Penicillamine—Lymphadenopathy—Topiramate—obesity	0.00186	0.00232	CcSEcCtD
Penicillamine—Tinnitus—Sibutramine—obesity	0.00184	0.0023	CcSEcCtD
Penicillamine—SLCO1B1—SLC-mediated transmembrane transport—SLC16A7—obesity	0.00183	0.0103	CbGpPWpGaD
Penicillamine—Blood alkaline phosphatase increased—Topiramate—obesity	0.00182	0.00227	CcSEcCtD
Penicillamine—Alopecia—Orlistat—obesity	0.0018	0.00225	CcSEcCtD
Penicillamine—Diarrhoea—Cimetidine—obesity	0.0018	0.00224	CcSEcCtD
Penicillamine—Angiopathy—Sibutramine—obesity	0.00179	0.00224	CcSEcCtD
Penicillamine—Mental disorder—Orlistat—obesity	0.00179	0.00223	CcSEcCtD
Penicillamine—Hepatic failure—Topiramate—obesity	0.00176	0.0022	CcSEcCtD
Penicillamine—Vomiting—Diethylpropion—obesity	0.00176	0.00219	CcSEcCtD
Penicillamine—Alopecia—Sibutramine—obesity	0.00175	0.00218	CcSEcCtD
Penicillamine—Rash—Diethylpropion—obesity	0.00174	0.00217	CcSEcCtD
Penicillamine—Dysgeusia—Orlistat—obesity	0.00174	0.00217	CcSEcCtD
Penicillamine—Dermatitis—Diethylpropion—obesity	0.00174	0.00217	CcSEcCtD
Penicillamine—Haemoglobin—Bupropion—obesity	0.00173	0.00216	CcSEcCtD
Penicillamine—Haemorrhage—Bupropion—obesity	0.00172	0.00215	CcSEcCtD
Penicillamine—Urinary tract disorder—Bupropion—obesity	0.0017	0.00212	CcSEcCtD
Penicillamine—Urethral disorder—Bupropion—obesity	0.00169	0.00211	CcSEcCtD
Penicillamine—Dysgeusia—Sibutramine—obesity	0.00168	0.0021	CcSEcCtD
Penicillamine—Vomiting—Cimetidine—obesity	0.00167	0.00208	CcSEcCtD
Penicillamine—Rash—Cimetidine—obesity	0.00166	0.00207	CcSEcCtD
Penicillamine—Dermatitis—Cimetidine—obesity	0.00165	0.00206	CcSEcCtD
Penicillamine—Nausea—Diethylpropion—obesity	0.00164	0.00205	CcSEcCtD
Penicillamine—Hypoglycaemia—Topiramate—obesity	0.00163	0.00203	CcSEcCtD
Penicillamine—Tinnitus—Bupropion—obesity	0.00161	0.002	CcSEcCtD
Penicillamine—Anaemia—Sibutramine—obesity	0.00159	0.00198	CcSEcCtD
Penicillamine—Agitation—Sibutramine—obesity	0.00158	0.00197	CcSEcCtD
Penicillamine—Angiopathy—Bupropion—obesity	0.00156	0.00195	CcSEcCtD
Penicillamine—Nausea—Cimetidine—obesity	0.00156	0.00195	CcSEcCtD
Penicillamine—Leukopenia—Sibutramine—obesity	0.00154	0.00192	CcSEcCtD
Penicillamine—Alopecia—Bupropion—obesity	0.00152	0.0019	CcSEcCtD
Penicillamine—Mental disorder—Bupropion—obesity	0.00151	0.00188	CcSEcCtD
Penicillamine—Anxiety—Orlistat—obesity	0.00151	0.00188	CcSEcCtD
Penicillamine—Unspecified disorder of skin and subcutaneous tissue—Orlistat—obesity	0.0015	0.00187	CcSEcCtD
Penicillamine—Dysgeusia—Bupropion—obesity	0.00147	0.00183	CcSEcCtD
Penicillamine—Arthralgia—Sibutramine—obesity	0.00146	0.00183	CcSEcCtD
Penicillamine—Anxiety—Sibutramine—obesity	0.00146	0.00182	CcSEcCtD
Penicillamine—Abdominal pain upper—Topiramate—obesity	0.00145	0.00181	CcSEcCtD
Penicillamine—Toxic epidermal necrolysis—Topiramate—obesity	0.00143	0.00178	CcSEcCtD
Penicillamine—Skin disorder—Orlistat—obesity	0.00141	0.00176	CcSEcCtD
Penicillamine—Muscular weakness—Topiramate—obesity	0.0014	0.00174	CcSEcCtD
Penicillamine—SLCO1B1—SLC-mediated transmembrane transport—SLC6A14—obesity	0.00139	0.0078	CbGpPWpGaD
Penicillamine—Anaemia—Bupropion—obesity	0.00139	0.00173	CcSEcCtD
Penicillamine—Agitation—Bupropion—obesity	0.00138	0.00172	CcSEcCtD
Penicillamine—Thrombocytopenia—Sibutramine—obesity	0.00137	0.00171	CcSEcCtD
Penicillamine—Asthma—Topiramate—obesity	0.00137	0.00171	CcSEcCtD
Penicillamine—Skin disorder—Sibutramine—obesity	0.00136	0.0017	CcSEcCtD
Penicillamine—Eosinophilia—Topiramate—obesity	0.00136	0.00169	CcSEcCtD
Penicillamine—Pancreatitis—Topiramate—obesity	0.00134	0.00168	CcSEcCtD
Penicillamine—Leukopenia—Bupropion—obesity	0.00134	0.00167	CcSEcCtD
Penicillamine—Anorexia—Sibutramine—obesity	0.00134	0.00167	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Orlistat—obesity	0.00132	0.00165	CcSEcCtD
Penicillamine—Pancytopenia—Topiramate—obesity	0.0013	0.00162	CcSEcCtD
Penicillamine—SLCO1B1—Bile acid and bile salt metabolism—ALB—obesity	0.00129	0.00723	CbGpPWpGaD
Penicillamine—Musculoskeletal discomfort—Sibutramine—obesity	0.00128	0.00159	CcSEcCtD
Penicillamine—Arthralgia—Bupropion—obesity	0.00128	0.00159	CcSEcCtD
Penicillamine—Anxiety—Bupropion—obesity	0.00127	0.00159	CcSEcCtD
Penicillamine—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	0.00127	0.00158	CcSEcCtD
Penicillamine—Decreased appetite—Orlistat—obesity	0.00126	0.00157	CcSEcCtD
Penicillamine—SLCO1B1—Transport of vitamins, nucleosides, and related molecules—ALB—obesity	0.00123	0.00693	CbGpPWpGaD
Penicillamine—Decreased appetite—Sibutramine—obesity	0.00122	0.00152	CcSEcCtD
Penicillamine—Renal failure—Topiramate—obesity	0.0012	0.0015	CcSEcCtD
Penicillamine—Neuropathy peripheral—Topiramate—obesity	0.0012	0.00149	CcSEcCtD
Penicillamine—Thrombocytopenia—Bupropion—obesity	0.0012	0.00149	CcSEcCtD
Penicillamine—Stomatitis—Topiramate—obesity	0.00119	0.00149	CcSEcCtD
Penicillamine—Skin disorder—Bupropion—obesity	0.00119	0.00148	CcSEcCtD
Penicillamine—Anorexia—Bupropion—obesity	0.00117	0.00145	CcSEcCtD
Penicillamine—Haematuria—Topiramate—obesity	0.00117	0.00145	CcSEcCtD
Penicillamine—Urticaria—Orlistat—obesity	0.00115	0.00144	CcSEcCtD
Penicillamine—SLCO1B1—SLC-mediated transmembrane transport—SLC9A3—obesity	0.00115	0.00646	CbGpPWpGaD
Penicillamine—Body temperature increased—Orlistat—obesity	0.00115	0.00143	CcSEcCtD
Penicillamine—Agranulocytosis—Topiramate—obesity	0.00114	0.00142	CcSEcCtD
Penicillamine—Urticaria—Sibutramine—obesity	0.00112	0.00139	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Bupropion—obesity	0.00111	0.00139	CcSEcCtD
Penicillamine—Body temperature increased—Sibutramine—obesity	0.00111	0.00138	CcSEcCtD
Penicillamine—Haemoglobin—Topiramate—obesity	0.0011	0.00138	CcSEcCtD
Penicillamine—Haemorrhage—Topiramate—obesity	0.0011	0.00137	CcSEcCtD
Penicillamine—SLCO1B1—SLC-mediated transmembrane transport—HK2—obesity	0.0011	0.00616	CbGpPWpGaD
Penicillamine—Urinary tract disorder—Topiramate—obesity	0.00108	0.00135	CcSEcCtD
Penicillamine—Urethral disorder—Topiramate—obesity	0.00108	0.00134	CcSEcCtD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—INSIG2—obesity	0.00107	0.00601	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—PPM1L—obesity	0.00107	0.00601	CbGpPWpGaD
Penicillamine—Hypersensitivity—Orlistat—obesity	0.00107	0.00133	CcSEcCtD
Penicillamine—Decreased appetite—Bupropion—obesity	0.00106	0.00133	CcSEcCtD
Penicillamine—SLCO1B1—SLC-mediated transmembrane transport—SLC27A1—obesity	0.00105	0.00591	CbGpPWpGaD
Penicillamine—Hypersensitivity—Sibutramine—obesity	0.00103	0.00129	CcSEcCtD
Penicillamine—Tinnitus—Topiramate—obesity	0.00102	0.00128	CcSEcCtD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—AQP7—obesity	0.00102	0.00572	CbGpPWpGaD
Penicillamine—Angiopathy—Topiramate—obesity	0.000996	0.00124	CcSEcCtD
Penicillamine—Diarrhoea—Orlistat—obesity	0.000992	0.00124	CcSEcCtD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—INPP5E—obesity	0.000978	0.0055	CbGpPWpGaD
Penicillamine—Urticaria—Bupropion—obesity	0.000972	0.00121	CcSEcCtD
Penicillamine—Alopecia—Topiramate—obesity	0.00097	0.00121	CcSEcCtD
Penicillamine—Body temperature increased—Bupropion—obesity	0.000967	0.00121	CcSEcCtD
Penicillamine—Mental disorder—Topiramate—obesity	0.000961	0.0012	CcSEcCtD
Penicillamine—Diarrhoea—Sibutramine—obesity	0.00096	0.0012	CcSEcCtD
Penicillamine—Dysgeusia—Topiramate—obesity	0.000935	0.00117	CcSEcCtD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—SLC16A7—obesity	0.00093	0.00523	CbGpPWpGaD
Penicillamine—Vomiting—Orlistat—obesity	0.000922	0.00115	CcSEcCtD
Penicillamine—Rash—Orlistat—obesity	0.000914	0.00114	CcSEcCtD
Penicillamine—Dermatitis—Orlistat—obesity	0.000914	0.00114	CcSEcCtD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—ME1—obesity	0.000909	0.00511	CbGpPWpGaD
Penicillamine—Hypersensitivity—Bupropion—obesity	0.000902	0.00112	CcSEcCtD
Penicillamine—Vomiting—Sibutramine—obesity	0.000892	0.00111	CcSEcCtD
Penicillamine—Rash—Sibutramine—obesity	0.000885	0.0011	CcSEcCtD
Penicillamine—Dermatitis—Sibutramine—obesity	0.000884	0.0011	CcSEcCtD
Penicillamine—Anaemia—Topiramate—obesity	0.000883	0.0011	CcSEcCtD
Penicillamine—Agitation—Topiramate—obesity	0.000878	0.00109	CcSEcCtD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—LCN2—obesity	0.000864	0.00486	CbGpPWpGaD
Penicillamine—Nausea—Orlistat—obesity	0.000861	0.00107	CcSEcCtD
Penicillamine—SLCO1B1—SLC-mediated transmembrane transport—HK1—obesity	0.00086	0.00484	CbGpPWpGaD
Penicillamine—Leukopenia—Topiramate—obesity	0.000855	0.00107	CcSEcCtD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—PNPLA3—obesity	0.000855	0.00481	CbGpPWpGaD
Penicillamine—Diarrhoea—Bupropion—obesity	0.000837	0.00104	CcSEcCtD
Penicillamine—Nausea—Sibutramine—obesity	0.000834	0.00104	CcSEcCtD
Penicillamine—Arthralgia—Topiramate—obesity	0.000813	0.00101	CcSEcCtD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—COX7C—obesity	0.000813	0.00457	CbGpPWpGaD
Penicillamine—Anxiety—Topiramate—obesity	0.00081	0.00101	CcSEcCtD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—DGAT2—obesity	0.00081	0.00456	CbGpPWpGaD
Penicillamine—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	0.000808	0.00101	CcSEcCtD
Penicillamine—Vomiting—Bupropion—obesity	0.000778	0.00097	CcSEcCtD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—MUT—obesity	0.000773	0.00435	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—LIPE—obesity	0.000773	0.00435	CbGpPWpGaD
Penicillamine—Rash—Bupropion—obesity	0.000772	0.000962	CcSEcCtD
Penicillamine—Dermatitis—Bupropion—obesity	0.000771	0.000961	CcSEcCtD
Penicillamine—Thrombocytopenia—Topiramate—obesity	0.000763	0.000952	CcSEcCtD
Penicillamine—SLCO1B1—SLC-mediated transmembrane transport—SLC22A1—obesity	0.00076	0.00427	CbGpPWpGaD
Penicillamine—Skin disorder—Topiramate—obesity	0.000757	0.000944	CcSEcCtD
Penicillamine—Anorexia—Topiramate—obesity	0.000743	0.000927	CcSEcCtD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—DGAT1—obesity	0.000741	0.00417	CbGpPWpGaD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—GABRA6—obesity	0.000735	0.00413	CbGpPWpGaD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—FTL—obesity	0.000735	0.00413	CbGpPWpGaD
Penicillamine—Nausea—Bupropion—obesity	0.000727	0.000906	CcSEcCtD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—ACLY—obesity	0.000713	0.00401	CbGpPWpGaD
Penicillamine—Musculoskeletal discomfort—Topiramate—obesity	0.00071	0.000886	CcSEcCtD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—SLC6A14—obesity	0.000705	0.00396	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—ALOX12—obesity	0.000689	0.00387	CbGpPWpGaD
Penicillamine—Decreased appetite—Topiramate—obesity	0.000678	0.000845	CcSEcCtD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—HMGCS1—obesity	0.000667	0.00375	CbGpPWpGaD
Penicillamine—SLCO1B1—SLC-mediated transmembrane transport—GCK—obesity	0.00066	0.00371	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—PNPLA2—obesity	0.000648	0.00364	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—ACADM—obesity	0.000648	0.00364	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—ANGPTL4—obesity	0.000648	0.00364	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—PLIN1—obesity	0.000648	0.00364	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—ACACB—obesity	0.00063	0.00354	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—OXCT1—obesity	0.00063	0.00354	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—CA3—obesity	0.000628	0.00353	CbGpPWpGaD
Penicillamine—Urticaria—Topiramate—obesity	0.000619	0.000772	CcSEcCtD
Penicillamine—Body temperature increased—Topiramate—obesity	0.000616	0.000769	CcSEcCtD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—SRD5A1—obesity	0.000614	0.00345	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—PNLIP—obesity	0.000614	0.00345	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—STS—obesity	0.000586	0.00329	CbGpPWpGaD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—SLC9A3—obesity	0.000584	0.00328	CbGpPWpGaD
Penicillamine—Hypersensitivity—Topiramate—obesity	0.000574	0.000716	CcSEcCtD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—PPARD—obesity	0.000573	0.00322	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—SLC27A1—obesity	0.000562	0.00316	CbGpPWpGaD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—HK2—obesity	0.000557	0.00313	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—FABP4—obesity	0.000551	0.0031	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—GLRX—obesity	0.000534	0.003	CbGpPWpGaD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—SLC27A1—obesity	0.000534	0.003	CbGpPWpGaD
Penicillamine—Diarrhoea—Topiramate—obesity	0.000533	0.000665	CcSEcCtD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—HSD11B1—obesity	0.000522	0.00294	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—ECHS1—obesity	0.000522	0.00294	CbGpPWpGaD
Penicillamine—SLCO1B1—SLC-mediated transmembrane transport—SLC2A4—obesity	0.000513	0.00289	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—ACSL1—obesity	0.000506	0.00284	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—GPAM—obesity	0.000506	0.00284	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—PPARGC1B—obesity	0.000506	0.00284	CbGpPWpGaD
Penicillamine—Vomiting—Topiramate—obesity	0.000496	0.000618	CcSEcCtD
Penicillamine—Rash—Topiramate—obesity	0.000492	0.000613	CcSEcCtD
Penicillamine—Dermatitis—Topiramate—obesity	0.000491	0.000612	CcSEcCtD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—HADH—obesity	0.000491	0.00276	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—FADS1—obesity	0.000491	0.00276	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—INSIG2—obesity	0.000476	0.00268	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—ETFDH—obesity	0.000476	0.00268	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—PPM1L—obesity	0.000476	0.00268	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—OTC—obesity	0.000476	0.00268	CbGpPWpGaD
Penicillamine—Nausea—Topiramate—obesity	0.000463	0.000578	CcSEcCtD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—SREBF2—obesity	0.00046	0.00259	CbGpPWpGaD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—TRPV1—obesity	0.000454	0.00255	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—LPA—obesity	0.000444	0.0025	CbGpPWpGaD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—HK1—obesity	0.000437	0.00246	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—GPT—obesity	0.000435	0.00245	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—UQCRC2—obesity	0.000435	0.00245	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—INPP5E—obesity	0.000435	0.00245	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—LPIN1—obesity	0.000434	0.00244	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—APOA5—obesity	0.000426	0.00239	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—CLOCK—obesity	0.000406	0.00228	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—ME1—obesity	0.000405	0.00228	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—SUCLG2—obesity	0.000405	0.00228	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—ALDH6A1—obesity	0.000405	0.00228	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—SULT2A1—obesity	0.000396	0.00223	CbGpPWpGaD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—SLC22A1—obesity	0.000386	0.00217	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—PNPLA3—obesity	0.000381	0.00214	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—COX7C—obesity	0.000381	0.00214	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—UCP1—obesity	0.000381	0.00214	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—CPT1A—obesity	0.000362	0.00204	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—CS—obesity	0.000361	0.00203	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—DGAT2—obesity	0.000361	0.00203	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—CPS1—obesity	0.000361	0.00203	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—SUCLA2—obesity	0.000361	0.00203	CbGpPWpGaD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—PRKAR2B—obesity	0.000356	0.002	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—LIPC—obesity	0.000353	0.00198	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—APOC3—obesity	0.00035	0.00197	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—LIPE—obesity	0.000344	0.00194	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—MUT—obesity	0.000344	0.00194	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—CETP—obesity	0.00034	0.00191	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—SDC1—obesity	0.000336	0.00189	CbGpPWpGaD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—GCK—obesity	0.000335	0.00189	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—AKR1C3—obesity	0.000331	0.00186	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—DGAT1—obesity	0.00033	0.00186	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—CYB5A—obesity	0.00033	0.00186	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—SCARB1—obesity	0.000326	0.00183	CbGpPWpGaD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—CETP—obesity	0.000323	0.00182	CbGpPWpGaD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—TF—obesity	0.00032	0.0018	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—ACLY—obesity	0.000318	0.00179	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—SREBF1—obesity	0.000316	0.00178	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—ENPP1—obesity	0.000307	0.00173	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—ALOX12—obesity	0.000307	0.00173	CbGpPWpGaD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—TFRC—obesity	0.000307	0.00173	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—FASN—obesity	0.000301	0.00169	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—BCHE—obesity	0.0003	0.00169	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—HMGCS1—obesity	0.000297	0.00167	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—ACADM—obesity	0.000288	0.00162	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—PNPLA2—obesity	0.000288	0.00162	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—PFKFB3—obesity	0.000288	0.00162	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—PLIN1—obesity	0.000288	0.00162	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—SAT1—obesity	0.000288	0.00162	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—ANGPTL4—obesity	0.000288	0.00162	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—CYTB—obesity	0.000281	0.00158	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—OXCT1—obesity	0.000281	0.00158	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—ACACB—obesity	0.000281	0.00158	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—PNLIP—obesity	0.000273	0.00154	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—SRD5A1—obesity	0.000273	0.00154	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—SDC3—obesity	0.000267	0.0015	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—GGT1—obesity	0.000266	0.00149	CbGpPWpGaD
Penicillamine—SLCO1B1—SLC-mediated transmembrane transport—ALB—obesity	0.000264	0.00149	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—NCOA1—obesity	0.000262	0.00147	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—HK2—obesity	0.000261	0.00147	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—STS—obesity	0.000261	0.00147	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—CYP26B1—obesity	0.000261	0.00147	CbGpPWpGaD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—SLC2A4—obesity	0.000261	0.00147	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—CYP19A1—obesity	0.000258	0.00145	CbGpPWpGaD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—CYCS—obesity	0.000257	0.00145	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—PPARD—obesity	0.000255	0.00144	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—SLC27A1—obesity	0.00025	0.00141	CbGpPWpGaD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—NCOA1—obesity	0.000249	0.0014	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—GLUL—obesity	0.000245	0.00138	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—FABP4—obesity	0.000245	0.00138	CbGpPWpGaD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—PLG—obesity	0.000242	0.00136	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—PPARGC1A—obesity	0.000236	0.00133	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—HSD11B1—obesity	0.000232	0.00131	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—UCP3—obesity	0.000232	0.00131	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—UCP2—obesity	0.000232	0.00131	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—ECHS1—obesity	0.000232	0.00131	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—ADH1B—obesity	0.000229	0.00129	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—APOB—obesity	0.000225	0.00127	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—PPARGC1B—obesity	0.000225	0.00127	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—ACSL1—obesity	0.000225	0.00127	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—GPAM—obesity	0.000225	0.00127	CbGpPWpGaD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—GNB3—obesity	0.000225	0.00126	CbGpPWpGaD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—HMOX1—obesity	0.000224	0.00126	CbGpPWpGaD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—GNAS—obesity	0.000219	0.00123	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—PCK1—obesity	0.000219	0.00123	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—HADH—obesity	0.000219	0.00123	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—FADS1—obesity	0.000219	0.00123	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—LPL—obesity	0.000215	0.00121	CbGpPWpGaD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—APOB—obesity	0.000214	0.00121	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—ACP5—obesity	0.000213	0.0012	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—GPX1—obesity	0.00021	0.00118	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—G6PD—obesity	0.000207	0.00117	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—SREBF2—obesity	0.000205	0.00115	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—HK1—obesity	0.000205	0.00115	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—CD36—obesity	0.000204	0.00115	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—LPA—obesity	0.000198	0.00111	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—LPIN1—obesity	0.000193	0.00109	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—PPARA—obesity	0.00019	0.00107	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—APOA5—obesity	0.00019	0.00107	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—AGT—obesity	0.000184	0.00104	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—CLOCK—obesity	0.000181	0.00102	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—SLC22A1—obesity	0.000181	0.00102	CbGpPWpGaD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—PPARA—obesity	0.000181	0.00102	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—obesity	0.00018	0.00101	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—CAV1—obesity	0.000179	0.00101	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—APOA1—obesity	0.000178	0.001	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—SULT2A1—obesity	0.000176	0.000991	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—GLP1R—obesity	0.000176	0.000991	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—DPYD—obesity	0.000173	0.000975	CbGpPWpGaD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—APOA1—obesity	0.00017	0.000954	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—PRKAR2B—obesity	0.000167	0.000939	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—DCN—obesity	0.000166	0.000932	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CG—obesity	0.000163	0.000916	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—CPT1A—obesity	0.000161	0.000907	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—NAMPT—obesity	0.000158	0.000889	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—obesity	0.000157	0.000884	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—LIPC—obesity	0.000157	0.000883	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—GCK—obesity	0.000157	0.000883	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—APOC3—obesity	0.000156	0.000878	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—POMC—obesity	0.000155	0.000872	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—CETP—obesity	0.000152	0.000852	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—SDC1—obesity	0.00015	0.000843	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—AKR1C3—obesity	0.000147	0.000829	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—SCARB1—obesity	0.000145	0.000816	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CD—obesity	0.000143	0.000805	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—obesity	0.000141	0.000795	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—SREBF1—obesity	0.000141	0.000792	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—GOT2—obesity	0.000137	0.000771	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3R1—obesity	0.000135	0.00076	CbGpPWpGaD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—ALB—obesity	0.000134	0.000756	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—FASN—obesity	0.000134	0.000754	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—BCHE—obesity	0.000134	0.000751	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—CYP2E1—obesity	0.000129	0.000725	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—NQO1—obesity	0.000127	0.000717	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CB—obesity	0.000125	0.000702	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—obesity	0.000124	0.000695	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—GCG—obesity	0.000122	0.000687	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—SLC2A4—obesity	0.000122	0.000687	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—CYCS—obesity	0.000121	0.000678	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—GGT1—obesity	0.000118	0.000665	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—GOT1—obesity	0.000118	0.000665	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—NCOA1—obesity	0.000117	0.000655	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—STK11—obesity	0.000115	0.000646	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—CYP19A1—obesity	0.000115	0.000646	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—COMT—obesity	0.000107	0.0006	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—GNB3—obesity	0.000105	0.000592	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—PPARGC1A—obesity	0.000105	0.000592	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—HMOX1—obesity	0.000105	0.000589	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—GNAS—obesity	0.000102	0.000577	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—APOB—obesity	0.0001	0.000565	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—LPL—obesity	9.58e-05	0.000539	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—GPX1—obesity	9.35e-05	0.000526	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—CD36—obesity	9.11e-05	0.000512	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—MTHFR—obesity	8.63e-05	0.000485	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—PPARA—obesity	8.46e-05	0.000476	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—AGT—obesity	8.2e-05	0.000461	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—APOE—obesity	8.03e-05	0.000452	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—CAV1—obesity	7.96e-05	0.000448	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—APOA1—obesity	7.94e-05	0.000447	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—obesity	7.6e-05	0.000428	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—PIK3CG—obesity	7.25e-05	0.000408	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—PPARG—obesity	7e-05	0.000394	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—POMC—obesity	6.9e-05	0.000388	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—INS—obesity	6.86e-05	0.000386	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—PIK3CD—obesity	6.37e-05	0.000359	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—ALB—obesity	6.29e-05	0.000354	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—PIK3R1—obesity	6.02e-05	0.000339	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—NOS3—obesity	6.02e-05	0.000339	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—PIK3CB—obesity	5.55e-05	0.000312	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—PTGS2—obesity	5.5e-05	0.00031	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—PIK3CA—obesity	3.39e-05	0.00019	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—AKT1—obesity	2.77e-05	0.000156	CbGpPWpGaD
